These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 23962496)

  • 1. Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.
    Heckman MG; Elbaz A; Soto-Ortolaza AI; Serie DJ; Aasly JO; Annesi G; Auburger G; Bacon JA; Boczarska-Jedynak M; Bozi M; Brighina L; Chartier-Harlin MC; Dardiotis E; Destée A; Ferrarese C; Ferraris A; Fiske B; Gispert S; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lin CH; Lohmann K; Loriot MA; Lynch T; Mellick GD; Mutez E; Opala G; Park SS; Petrucci S; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Tomiyama H; Uitti RJ; Valente EM; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Xiromerisiou G; Maraganore DM; Farrer MJ; Ross OA;
    Neurobiol Aging; 2014 Jan; 35(1):266.e5-14. PubMed ID: 23962496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility?
    Biernacka JM; Armasu SM; Cunningham JM; Ahlskog JE; Chung SJ; Maraganore DM
    Parkinsonism Relat Disord; 2011 Dec; 17(10):730-6. PubMed ID: 21816655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients.
    Boros FA; Török R; Vágvölgyi-Sümegi E; Pesei ZG; Klivényi P; Vécsei L
    Neurosci Lett; 2019 Jul; 706():140-145. PubMed ID: 31085292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LRRK2 N551K and R1398H variants are protective in Malays and Chinese in Malaysia: A case-control association study for Parkinson's disease.
    Gopalai AA; Lim JL; Li HH; Zhao Y; Lim TT; Eow GB; Puvanarajah S; Viswanathan S; Norlinah MI; Abdul Aziz Z; Lim SK; Tan CT; Tan AH; Lim SY; Tan EK; Ahmad Annuar A
    Mol Genet Genomic Med; 2019 Nov; 7(11):e604. PubMed ID: 31487119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.
    Elbaz A; Ross OA; Ioannidis JP; Soto-Ortolaza AI; Moisan F; Aasly J; Annesi G; Bozi M; Brighina L; Chartier-Harlin MC; Destée A; Ferrarese C; Ferraris A; Gibson JM; Gispert S; Hadjigeorgiou GM; Jasinska-Myga B; Klein C; Krüger R; Lambert JC; Lohmann K; van de Loo S; Loriot MA; Lynch T; Mellick GD; Mutez E; Nilsson C; Opala G; Puschmann A; Quattrone A; Sharma M; Silburn PA; Stefanis L; Uitti RJ; Valente EM; Vilariño-Güell C; Wirdefeldt K; Wszolek ZK; Xiromerisiou G; Maraganore DM; Farrer MJ;
    Ann Neurol; 2011 May; 69(5):778-92. PubMed ID: 21391235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAPT IVS1+124 C>G modifies risk of LRRK2 G2385R for Parkinson's disease in Chinese individuals.
    Dan X; Wang C; Ma J; Feng X; Wang T; Zheng Z; Chan P
    Neurobiol Aging; 2014 Jul; 35(7):1780.e7-1780.e10. PubMed ID: 24559644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.
    Ross OA; Soto-Ortolaza AI; Heckman MG; Aasly JO; Abahuni N; Annesi G; Bacon JA; Bardien S; Bozi M; Brice A; Brighina L; Van Broeckhoven C; Carr J; Chartier-Harlin MC; Dardiotis E; Dickson DW; Diehl NN; Elbaz A; Ferrarese C; Ferraris A; Fiske B; Gibson JM; Gibson R; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lesage S; Lin CH; Lynch T; Maraganore DM; Mellick GD; Mutez E; Nilsson C; Opala G; Park SS; Puschmann A; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Theuns J; Tomiyama H; Uitti RJ; Valente EM; van de Loo S; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Farrer MJ;
    Lancet Neurol; 2011 Oct; 10(10):898-908. PubMed ID: 21885347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study.
    Wider C; Vilariño-Güell C; Heckman MG; Jasinska-Myga B; Ortolaza-Soto AI; Diehl NN; Crook JE; Cobb SA; Bacon JA; Aasly JO; Gibson JM; Lynch T; Uitti RJ; Wszolek ZK; Farrer MJ; Ross OA
    Eur J Neurol; 2011 Jun; 18(6):876-81. PubMed ID: 21159074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SNCA but not DNM3 and GAK modifies age at onset of LRRK2-related Parkinson's disease in Chinese population.
    Yang ZH; Li YS; Shi MM; Yang J; Liu YT; Mao CY; Fan Y; Hu XC; Shi CH; Xu YM
    J Neurol; 2019 Jul; 266(7):1796-1800. PubMed ID: 31041581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic susceptibility loci, environmental exposures, and Parkinson's disease: a case-control study of gene-environment interactions.
    Chung SJ; Armasu SM; Anderson KJ; Biernacka JM; Lesnick TG; Rider DN; Cunningham JM; Ahlskog JE; Frigerio R; Maraganore DM
    Parkinsonism Relat Disord; 2013 Jun; 19(6):595-9. PubMed ID: 23507417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
    Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C
    Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson's disease.
    Wang G; Huang Y; Chen W; Chen S; Wang Y; Xiao Q; Liu J; Fung VS; Halliday G; Chen S
    Parkinsonism Relat Disord; 2016 Mar; 24():89-94. PubMed ID: 26776090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age at onset in LRRK2-associated PD is modified by SNCA variants.
    Botta-Orfila T; Ezquerra M; Pastor P; Fernández-Santiago R; Pont-Sunyer C; Compta Y; Lorenzo-Betancor O; Samaranch L; Martí MJ; Valldeoriola F; Calopa M; Fernández M; Aguilar M; de Fabregas O; Hernández-Vara J; Tolosa E
    J Mol Neurosci; 2012 Sep; 48(1):245-7. PubMed ID: 22669510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SNCA Gene, but Not MAPT, Influences Onset Age of Parkinson's Disease in Chinese and Australians.
    Huang Y; Wang G; Rowe D; Wang Y; Kwok JB; Xiao Q; Mastaglia F; Liu J; Chen SD; Halliday G
    Biomed Res Int; 2015; 2015():135674. PubMed ID: 25960998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants of SNCA and LRRK2 genes are associated with sporadic PD susceptibility: a replication study in a Taiwanese cohort.
    Wu-Chou YH; Chen YT; Yeh TH; Chang HC; Weng YH; Lai SC; Huang CL; Chen RS; Huang YZ; Chen CC; Hung J; Chuang WL; Lin WY; Chen CH; Lu CS
    Parkinsonism Relat Disord; 2013 Feb; 19(2):251-5. PubMed ID: 23182315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The age at motor symptoms onset in LRRK2-associated Parkinson's disease is affected by a variation in the MAPT locus: a possible interaction.
    Gan-Or Z; Bar-Shira A; Mirelman A; Gurevich T; Giladi N; Orr-Urtreger A
    J Mol Neurosci; 2012 Mar; 46(3):541-4. PubMed ID: 21898123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polygenic determinants of Parkinson's disease in a Chinese population.
    Guo JF; Li K; Yu RL; Sun QY; Wang L; Yao LY; Hu YC; Lv ZY; Luo LZ; Shen L; Jiang H; Yan XX; Pan Q; Xia K; Tang BS
    Neurobiol Aging; 2015 Apr; 36(4):1765.e1-1765.e6. PubMed ID: 25623333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SNCA, LRRK2, MAPT polymorphisms and Parkinson's disease in Russia.
    Emelyanov A; Andoskin P; Yakimovskii A; Usenko T; Nuzhnyi E; Nikolaev M; Pchelina S
    Parkinsonism Relat Disord; 2013 Nov; 19(11):1064-5. PubMed ID: 23830801
    [No Abstract]   [Full Text] [Related]  

  • 19. SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population.
    Trotta L; Guella I; Soldà G; Sironi F; Tesei S; Canesi M; Pezzoli G; Goldwurm S; Duga S; Asselta R
    Parkinsonism Relat Disord; 2012 Mar; 18(3):257-62. PubMed ID: 22104010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical genetics of Parkinson's disease and related disorders.
    Wider C; Wszolek ZK
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S229-32. PubMed ID: 18267241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.